Addex Therapeutics Ltd Cash Flows From Used In Financing Activities
Addex Therapeutics Ltd (ADXN) reported Cash Flows From Used In Financing Activities of CHF 747.18 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2025-09-30
| Period end | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|
| 2025-06-30 | 747.18K CHF 6-K · filed 2025-09-30 | |
| 2024-12-31 | 104.92K CHF 20-F · filed 2025-05-15 | |
| 2024-06-30 | 107.14K CHF 6-K · filed 2025-09-30 | |
| 2023-12-31 | 5.26M CHF 20-F · filed 2025-05-15 | |
| 2023-06-30 | 5.51M CHF 6-K/A · filed 2023-12-21 | |
| 2022-12-31 | 3.10M CHF 20-F · filed 2025-05-15 | |
| 2022-06-30 | -914.61K CHF 6-K/A · filed 2023-12-21 | |
| 2021-12-31 | 16.40M CHF 20-F · filed 2024-04-18 | |
| 2021-06-30 | 8.34M CHF 6-K/A · filed 2022-09-14 | |
| 2020-12-31 | 46.40K CHF 20-F · filed 2023-03-30 | |
| 2019-12-31 | -463.69K CHF 20-F · filed 2022-03-10 | |
| 2018-12-31 | 37.39M CHF 20-F · filed 2021-03-11 | |
| 2017-12-31 | 3.36M CHF 20-F · filed 2020-04-27 |